Syntax Research, Inc. Globus Medical Inc Transaction History
Syntax Research, Inc.
- $126 Billion
- Q2 2024
A detailed history of Syntax Research, Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Syntax Research, Inc. holds 1,000 shares of GMED stock, worth $81,100. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$81,100
Previous $53.6 Million
27.68%
% of portfolio
0.05%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding GMED
# of Institutions
478Shares Held
104MCall Options Held
183KPut Options Held
57.3K-
Vanguard Group Inc Valley Forge, PA10.6MShares$862 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$839 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07MShares$568 Million0.27% of portfolio
-
State Street Corp Boston, MA3.57MShares$290 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$211 Million0.02% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $6.25B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...